Featured Speakers
![](images/speakers/138.jpg)
Absalom Zamorano-Carrillo, Escuela Nacional de Medicina y Homeopatía, Mexico
Title: Computational prediction of a continuous peptide epitope reacting with pandemic influenza AH1N1
![](images/speakers/1.jpg)
Alan S Cross, University of Maryland at Baltimore, USA
Title: Back to the future: Anti-endotoxin vaccines for multidrug-resistant gram-negative bacteria
![](images/speakers/60.jpg)
Ali I. Fattom, NanoBio Corporation, USA
Title: Nanoemulsion delivery/adjuvant for eliciting mucosal immunity a key in protection against respiratory and sexually transmitted infections
![](images/speakers/132.jpg)
Amanda Arnold, The Texas A&M University, USA
Title: Advancing wildlife biosurveillance and vaccine science: Epidemic preparedness at the human/animal interface
![](images/speakers/63.jpg)
Amita Joshi, Merck & Co, USA
Title:
![](images/speakers/noimage.jpg)
Andrea Facciabene, University of Pennsylvania School of Medicine, USA
Title: A Tumor Mitochondria Vaccine Protects Against Experimental Renal Cell Carcinoma
![](images/speakers/2.jpg)
Andrew J Geall, GSK, USA
Title: Non-viral delivery of self-amplifying mRNA vaccines
![](images/speakers/72.jpg)
Andrew Lees, Fina BioSolutions, USA
Title: Towards affordable conjugate vaccines: Efficient chemistry and low cost CRM197 carrier protein
![](images/speakers/76.jpg)
Armando Zuniga, Virometix AG, Switzerland
Title: Synthetic Virus-Like Particles (SVLPs) for the development of fully synthetic prophylactic vaccines
![](images/speakers/101.jpg)
Arvind Chhabra, University of Connecticut Health Center, USA
Title: Generation of donor specific customized anti-tumor T cells and antigen presenting cells for personalized cancer immunotherapy
![](images/speakers/75.jpg)
Barbara K. Felber, National Cancer Institute, USA
Title: Novel DNA vaccine strategy to alter HIV immune hierarchy
![](images/speakers/47.jpg)
Bernadette Ferraro, Inovio Pharmaceuticals, USA
Title: DNA vaccines for cancer immunotherapy
![](images/speakers/92.jpg)
Betsy C. Herold, Albert Einstein College of Medicine, USA
Title: Vaccines for HSV prevention: Rethinking the role of neutralizing antibodies
![](images/speakers/135.jpg)
Bok Luel Lee, Pusan National University, Korea
Title: Novel staphylococcal cell wall component functions as an antigen molecule of T cell subset: a valuable vaccine candidate for MRSA infection
![](images/speakers/81.jpg)
Brian J. Czerniecki, University of Pennsylvania, USA
Title: Loss of anti-her-2 immunity and the potential for immune restoration in breast cancer therapy
![](images/speakers/67.jpg)
Carmen Alvarez-Dominguez, Instituto de Investigacion Marques de Valdecilla, Spain
Title: A novel therapy for melanoma developed in mice: Transformation of melanoma into dendritic cells with Listeria monocytogenes
![](images/speakers/noimage.jpg)
Catherine N. Kibirige, Johns Hopkins Bloomberg School of Public Health, USA
Title: The use of ultra-sensitive laboratory developed assays in HIV-1 vaccine and cure research
![](images/speakers/6.jpg)
Cécile BAUCHE, Theravectys, France
Title: Development of a new immunotherapeutic platform based on the use of lentiviral vectors
![](images/speakers/86.jpg)
Charani Ranasinghe, The Australian National University, Australia
Title: Novel IL-4R antagonist and IL-13Ra2 adjuvanted HIV vaccines can induce excellent high quality T and B cell immunity
![](images/speakers/50.jpg)
Christopher Heery, National Cancer Institute, USA
Title: Development of therapeutic cancer vaccines targeting the transcription factor, brachyury
![](images/speakers/noimage.jpg)
Colin G. Hebert, LumaCyte, LLC, USA
Title: Rapid Viral Detection and Quantification Using Laser Force Analysis
![](images/speakers/84.jpg)
Chul-Joong Kim, Chungnam National University, Korea
Title: Surface-display platform for mucosal vaccine against influenza and HPV infection
![](images/speakers/noimage.jpg)
Dal Young Kim, University of Alabama at Birmingham, USA
Title: Next Generation Alphavirus-based expression systems and its application
![](images/speakers/80.jpg)
Daniel H Zimmerman, CEL-SCI Corporation, USA
Title: Vaccines: Moving into IND enabling studies and beyond- using SBIR grants in part and as leverage
![](images/speakers/116.jpg)
Daniel Janies, The University of North Carolina at Charlotte, USA
Title: Genes, evolution, and geography of pathogens
![](images/speakers/108.jpg)
Daniel Wattendorf, DARPA Biological Technologies Office, USA
Title: Novel Nucleic Acid-Based Immunoprophylaxis Technologies
![](images/speakers/noimage.jpg)
Dao Huang, Transgene Biopharmaceutical Technology, China
Title: The sero-prevalence of anti-adenovirus 5 neutralizing antibodies is independent of a chronic hepatitis B carrier state in China
![](images/speakers/8.jpg)
De-chu Christopher Tang, VaxDome LLC, USA
Title: Activation of protective innate-adaptive immunity duo for conferring rapid-sustained-broad protection of vaccines against influenza
![](images/speakers/97.jpg)
Denise L Faustman, Harvard Medical School, USA
Title: Resurgence of phase I-phase III global trials multi-dosing BCG for autoimmunity and allergies
![](images/speakers/9.jpg)
Dennis Klinman, National Cancer Institute, USA
Title: Utility of CpG oligonucleotides as vaccine adjuvants
![](images/speakers/noimage.jpg)
Diane Williamson, Defence Science & Technology Laboratory, UK
Title: Novel approach to therapeutic vaccination for bacterial infection
![](images/speakers/93.jpg)
Douglas E. Brough, GenVec, Inc., USA
Title: Gorilla adenovirus vectors for molecular therapeutics and vaccines
![](images/speakers/noimage.jpg)
Drew Hannaman, Ichor Medical Systems, Inc., USA
Title: Phase I Clinical Study of a Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate Delivered by Electroporation Mediated Intradermal or Intramuscular Administration
![](images/speakers/79.jpg)
Duane A. Mitchell, University of Florida, USA
Title: Vaccines targeting CMV antigens in glioblastoma
![](images/speakers/120.jpg)
E George Elias, University of Maryland St. Joseph Medical Center, USA
Title: Sequential Intralesional Administration with Low Dose GM-CSF and IL-2 in Melanoma Lesions Can Induce Immense Antitumor Response that Reflects on Patient Survival
![](images/speakers/88.jpg)
Eelko Hak, University of Groningen, The Netherlands
Title: Novel designs to assess conventional influenza vaccine effectiveness and potential role of universal vaccines
![](images/speakers/54.jpg)
Emmanuel Drouet, Université de Grenoble-Alpes, France
Title: Epstein-Barr Virus in the breast cancer tissue: friend or foe?
![](images/speakers/64.jpg)
Eric Aubin, Medicago, USA
Title: Progress in the clinical development of the plant-made influenza VLP vaccines
![](images/speakers/noimage.jpg)
Eva van Doorn, University Groningen, The Netherlands
Title: National Differences in Requirements for Ethical and Competent Authority Approval for a Multinational Vaccine Trial under the EU Directive 2001/20/EC
![](images/speakers/107.jpg)
Frank R. Jones, Etubics Corporation, USA
Title: A Novel HPV-16 Immunotherapeutic Vaccine Plus PD-1 Checkpoint Inhibition Results in Induction of Heightened Cell Mediated Immunity and Anti-Tumor Responses
![](images/speakers/12.jpg)
Geert Vanden Bossche, Univac NV, Belgium
Title: Effective vaccine design back to the drawing board?
![](images/speakers/82.jpg)
Genevieve G Fouda Amouou, Duke University Medical Center, USA
Title: HIV vaccine-elicited antibody responses in infants
![](images/speakers/46.jpg)
George N Pavlakis, National Cancer Institute, USA
Title: New methods for vaccines and immunotherapies for HIV
![](images/speakers/13.jpg)
Gergana Galabova, AFFiRiS AG, Austria
Title: PCSK9 vaccines – a novel immunotherapy for the treatment of hypercholesterolemia
![](images/speakers/14.jpg)
Giulio Tarro, Temple University College of Science and Technology, USA
Title: Oncogenic viruses and tumor associated antigens vaccines
![](images/speakers/134.jpg)
Greg A. Snyder, University of Maryland School of Medicine, USA
Title: Targeting intracellular toll-like and interleukin receptor signaling pathways for immune modulation and protection against lethal microbial infection
![](images/speakers/15.jpg)
Hanping Feng, University of Maryland at Baltimore, USA
Title:
![](images/speakers/85.jpg)
Hao Zeng, National Immune Products Engineering Technology Research Center, China
Title: Research progress in immune escape and immune prevention of MRSA Infection
![](images/speakers/16.jpg)
Harry Kleanthous, Sanofi Pasteur, USA
Title: Universal influenza vaccines: Prevention of infection against matched and mismatched strains
![](images/speakers/56.jpg)
Hira Nakhasi, Food and Drug Administration, USA
Title: Safety and effectiveness of genetically modified live attenuated Leishmania donovani vaccine candidates
![](images/speakers/noimage.jpg)
Hatice Karauzum, NIH/NIAID, USA
Title: Site-specific Immune Requirements for Vaccine-mediated Protection and Immunopathology against Staphylococcus aureus
![](images/speakers/17.jpg)
Indresh Srivastava, Protein Sciences, USA
Title:
![](images/speakers/102.jpg)
Ingrid Scully, Pfizer, USA
Title: Designing a Staphylococcus aureus vaccine for a new century
![](images/speakers/123.jpg)
Ivan Ruzic, BehaviorMatrix, LLC, USA
Title: Effective Global Pandemic Indications, Warning and Response Systems
![](images/speakers/noimage.jpg)
Jae-Woong Lee, The Catholic University of Korea, South Korea
Title: Recombination analysis based on HAstV-2 and HAstV-8 complete genome in south korea
![](images/speakers/99.jpg)
Jagannadha Sastry, The University of Texas MD Anderson Cancer Center, USA
Title: Mucosal vaccination and checkpoint modulation for curative therapy of HPV cancers
![](images/speakers/noimage.jpg)
James Mond, ADMA Biologics Inc, USA
Title: Intravenous immune globulin (IGIV) containing high titer neutralizing antibodies to respiratory syncytial virus (RSV) and other respiratory viruses (RI-002)
![](images/speakers/124.jpg)
Jane Homan, EigenBio LLC., USA
Title: A systems biology approach to vaccine design: We have found the epitopes and they are us
![](images/speakers/109.jpg)
Jay A Berzofsky, National Cancer Institute, USA
Title: Cancer Vaccines: Translation from mice to human clinical trials
![](images/speakers/119.jpg)
Jay H. Bream, Johns Hopkins Bloomberg School of Public Health, USA
Title: Heterotypic T cell responses to inactivated and live attenuated seasonal influenza vaccines
![](images/speakers/133.jpg)
Jeevan Malaiyan, Sri Muthukumaran Medical College Hospital and Research Institute, India
Title: Studies on mumps virus infection, genotype identification of circulating strains among MMR vaccine recipients
![](images/speakers/21.jpg)
Jeffrey I. Cohen, Medical Virology Section, LID, NIH , USA
Title: Epstein-Barr virus vaccines
![](images/speakers/105.jpg)
Jennifer Schwartz, Profectus Biosciences, USA
Title: Full length single chain, a novel gp120-CD4 fusion HIV subunit vaccine, does not cause a deleterious autoimmune CD4 response in cynomolgus macaques
![](images/speakers/noimage.jpg)
Jianhua Le, New York Medical College, USA
Title: Development of high yield reassortants for influenza type B viruses and analysis of their gene compositions
![](images/speakers/69.jpg)
John F Kearney, University of Alabama at Birmingham, USA
Title: Can anti-streptococcal vaccines be used to protect against fungal infections?
![](images/speakers/111.jpg)
John Robert Coleman Codagenix, Inc., USA
Title: An Ultra-low Dose Live Influenza Vaccine Enabling Rapid Production
![](images/speakers/45.jpg)
Joost Oppenheim, National Cancer Institute, USA
Title: The antitumor effects of the HMGN1 alarmin
![](images/speakers/noimage.jpg)
Jorge Blanco, Sigmovir Biosystems, Inc., USA
Title: Deciphering Maternal Transfer of Immunity for optimization of RSV vaccination in future mothers
![](images/speakers/130.jpg)
Jose M Galarza, TechnoVax, Inc., USA
Title: A Virus-Like Particle (VLP) Respiratory Syncytial Virus Vaccine Composed of Distinct Conformation of the F Glycoprotein F Affords Complete Protection Against RSV Challenge in a Murine Model of the Disease
![](images/speakers/61.jpg)
Juan Carlos Zapata, University of Maryland at Baltimore, USA
Title: Vaccine platforms for lassa fever
![](images/speakers/78.jpg)
K. Gus Kousoulas, LSU-Tulane NIH Center for Biomedical Research Excellence, USA
Title: Intramuscular vaccination with the live-attenuated herpes simplex virus type-1 vaccine strain VC2 generates robust immune responses in rhesus macaques and fully protects mice against lethal intravaginal and intraocular infection
![](images/speakers/44.jpg)
Kathy L. Rowlen, InDevR, Inc., USA
Title: Influenza HA Potency in Monovalent and Quadrivalent Formulations
![](images/speakers/23.jpg)
Kathleen Hefferon, University of Toronto, Canada
Title: Plant-derived vaccines for developing countries
![](images/speakers/24.jpg)
Kenneth Bagley, Profectus Biosciences, USA
Title: An IL-12 adjuvanted HSV-2 DNA vaccine is more protective than a glycoprotein D subunit vaccine in a high-dose murine challenge model
![](images/speakers/25.jpg)
Kimberly S. Schluns, The University of Texas MD Anderson Cancer Center , USA
Title: Production of soluble IL-15 complexes by pathogen infections and adjuvants
![](images/speakers/91.jpg)
Kishore Alugupalli, Thomas Jefferson University, USA
Title: Identification of a basis for the impaired responses to bacterial polysaccharide vaccines in young children
![](images/speakers/noimage.jpg)
Krishnamurthy Konduru, Food and Drug Administration, USA
Title: Evaluation of ebolavirus glycoprotein Fc fusion protein as a subunit vaccine
![](images/speakers/26.jpg)
Kwong Y Tsang, National Cancer Institute, USA
Title: Immune responses of carcinoma patients to tumor associated antigens
![](images/speakers/noimage.jpg)
Latifynia Afshineh, Tehran University of Medical Sciences, Iran
Title: Cytokine assay (ILs 4, 10, 12, 17, 23, IFN-γ), CD8+& CD4+ in pre challenge Balb/c mice vaccinated by the Leishmania major new vaccine
![](images/speakers/96.jpg)
Leonard Friedland, GSK, USA
Title: Vaccine e adjuvant science
![](images/speakers/129.jpg)
Linda McKibben, Food and Drug Administration, USA
Title: Working Together to Advance Vaccinomics in Efficacy and Safety Studies
![](images/speakers/104.jpg)
Lewis Schrager, AERAS, USA
Title: Developing vaccines for tuberculosis: Current challenges and strategies
![](images/speakers/27.jpg)
Magdalena Tary Lehmann, Cellular Technology Limited, USA
Title: Adjuvant-guidance of T cell mediate immune responses
![](images/speakers/137.jpg)
Malabi M. Venkatesan Walter Reed Army Institute of Research, USA
Title: Live attenuated anti-dysentery shigella vaccine candidates
![](images/speakers/118.jpg)
Manuel Elkin Patarroyo, Fundacion Instituto de Inmunologia de Colombia, Colombia
Title: Immune Protection Inducing Synthetic Protein Structures (IMPIPS): The New vaccines
![](images/speakers/121.jpg)
María Marcela Barrio, Centro de Investigaciones Oncológicas-Fundación Cáncer, Argentina
Title: A randomized Phase II study of the CSF-470 therapeutic vaccine plus BCG plus rhGM-CSF versus IFN-α2b in Cutaneous Melanoma patients stages IIB, IIC and III
![](images/speakers/125.jpg)
Marina Boukhvalova, Sigmovir Biosystems, Inc., USA
Title: Vaccines against HSV-2 and HSV-1 genital herpes: lessons from the cotton rat model
![](images/speakers/28.jpg)
Maria Eugenia Rodrigez, UNIVERSIDAD NACIONAL DE LA PLATA, Argentina
Title: Pertussis vaccine efficacy against old and novel circulating bacteria can be improved by the addition of two new vaccine candidates
![](images/speakers/103.jpg)
Marjorie Robert-Guroff, National Cancer Institute, USA
Title: Uncovering a sex bias in SIV vaccine-induced protection
![](images/speakers/29.jpg)
Mark A. Tomai, 3M Company, USA
Title: The use of the TLR 7/8 agonist 3M-052 as a potent vaccine adjuvant
![](images/speakers/115.jpg)
Mark L Bagarazzi, Inovio Pharmaceuticals, USA
Title: Histologic Regression of Cervical Intraepithelial Neoplasia (CIN) after Treatment with VGX-3100, Therapeutic HPV16/18 DNA Vaccine
![](images/speakers/100.jpg)
Mark S Riddle, Navy Medical Research Center, USA
Title: Updates in shigella vaccine development
![](images/speakers/114.jpg)
Martin Moore, Emory+Children's Center for Childhood Infections and Vaccines (CCIV), USA
Title: A novel live, attenuated respiratory syncytial virus vaccine with rationally designed immunogenicity, stability, and enhanced pre-fusion F expression
![](images/speakers/122.jpg)
Masato Okamoto, Kitasato University School of Pharmacy, Japan
Title: Development of dendritic cell-based cancer vaccine in Japan
![](images/speakers/98.jpg)
Michael A. Barry, Mayo Clinic, USA
Title: Single-cycle replicating adenovirus vaccines
![](images/speakers/31.jpg)
Michael G Hanna, Vaccinogen Inc., USA
Title: The provocative issue of tumor genomic heterogeneity in immunotherapy
![](images/speakers/32.jpg)
Michael Hust, Technische Universität Braunschweig, Germany
Title: Developing human and human-like antibodies against pathogens and toxins for diagnostics and therapy
![](images/speakers/51.jpg)
Michael J. Lacy, Emergent BioSolutions, USA
Title: Fewer Linear Epitopes with a squalene formulation
![](images/speakers/131.jpg)
Mitsuru Akashi, Osaka University, Japan
Title: Nanoparticle Vaccine: Antigen Protein Delivery to Dendritic Cells Using Amphiphilic Poly(amino Acid) Derivatives
![](images/speakers/128.jpg)
Mohammad Javad Gharagozlou, University of Tehran, Iran
Title: Evaluation of serum levels of IL-17 and Il-23 and spleen white pulp changes of Balb/C mice following administration of new formulation of Leishmania major antigen as provisional vaccine
![](images/speakers/139.jpg)
Monjori Mitra, Institute of Child Health, India
Title: Long term follow-up study to evaluate immunogenicity and safety of a single dose of live attenuated Hepatitis A vaccine in children
![](images/speakers/112.jpg)
Myron M. Levine, University of Maryland School of Medicine, USA
Title: Vaccines Against Invasive Salmonella Infections
![](images/speakers/74.jpg)
Nabil Al-Humadi, FDA/CBER, USA
Title: Pre-clinical toxicology considerations in vaccine
![](images/speakers/noimage.jpg)
Nicolas Çuburu, National Cancer Institute, USA
Title: Viral vector-based prime/boost vaccination to maximize tissue-resident memory T cell responses in the cervicovaginal mucosa
![](images/speakers/34.jpg)
Norman W. Baylor, Biologics Consulting Group, Inc., USA
Title: Regulatory perspective on the evaluation of new vaccine technologies
![](images/speakers/71.jpg)
Osama Rahma, University of Virginia, USA
Title: A novel clinical trials design for combination therapy of cancer vaccines and immune modulators
![](images/speakers/117.jpg)
Par Comstedt, Valneva Austria GmbH, Austria
Title: Design and development of a novel vaccine for protection against Lyme borreliosis
![](images/speakers/59.jpg)
Peter Johannes Holst, University of Copenhagen, Denmark
Title: Genetic adjuvants that improve the T cell and antibody response induced by virus-vectored vaccines
![](images/speakers/83.jpg)
Peter Timms, University of the Sunshine Coast, Australia
Title: Progress towards the development a chlamydial vaccine for koalas
![](images/speakers/noimage.jpg)
Qihan Li, Chinese Academy of Medical Sciences, China
Title: The characterized immune response and the evaluation vaccines of EV71 and CA16
![](images/speakers/68.jpg)
Ravi A. Madan, National Cancer Institute, USA
Title: Integrating therapeutic cancer vaccines into treatment for prostate cancer
![](images/speakers/noimage.jpg)
Rezwanul Wahid, University of Maryland School of Medicine, USA
Title: Cross-reactive multifunctional T cell responses to Salmonella enterica serovars in humans
![](images/speakers/110.jpg)
Robert W Malone, RW Malone MD, LLC, USA
Title: Ebola Vaccine in 12 months, Global Village, and the Need for Speed
![](images/speakers/94.jpg)
Scott C. Quinlan, HealthCore, Inc. USA
Title: Lessons learned from studying vaccination administration and completion using a large administrative claims database
![](images/speakers/37.jpg)
Shahin Gharakhanian, Cambridge Innovation Center, USA
Title: Methodological challenges in the clinical development of HIV therapeutic vaccines for the functional cure of HIV infection
![](images/speakers/126.jpg)
Shiladitya DasSarma, University of Maryland School of Medicine, USA
Title: Gas Vesicle Nanoparticles for Antigen Display and Vaccine Development
![](images/speakers/62.jpg)
Sita Awasthi, University of Pennsylvania, USA
Title: A genital herpes vaccine that targets viral entry and blocks evasion of host immunity
![](images/speakers/70.jpg)
Sushma Kommareddy, Novartis, USA
Title: Prospects and challenges for microneedle delivery of influenza vaccines
![](images/speakers/noimage.jpg)
Tarek Fahmy, Yale University School of Medicine, USA
Title:
![](images/speakers/noimage.jpg)
Theodore Schenkelberg, Human Vaccines Project, USA
Title: The human vaccines project: Changing the paradigm of Vaccine R&D
![](images/speakers/73.jpg)
Thomas H. King, GlobeImmune, Inc., USA
Title: Whole recombinant yeast-based vaccines for the prevention and treatment of multidrug resistant tuberculosis
![](images/speakers/40.jpg)
Timothy Fouts, Profectus Biosciences, USA
Title: Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection
![](images/speakers/127.jpg)
Tian Wang, University of Texas Medical Branch, USA
Title: Role of toll-like receptor signaling in regulating adaptive immunity against a candidate live attenuated West Nile virus vaccine strain infection
![](images/speakers/41.jpg)
Tong-Ming Fu, Merck Research Laboratories, USA
Title: A replication defective human cytomegalovirus (CMV) vaccine
![](images/speakers/noimage.jpg)
Ulrike Diesterbeck, NIH/NIAID, USA
Title: Neutralizing recombinant human antibodies against the vaccinia virus d8 protein derived from an immunized immunoglobulin library
![](images/speakers/noimage.jpg)
Ursula Buchholz, NIH/NIAID, USA
Title: Development of live attenuated RSV vaccines
![](images/speakers/noimage.jpg)
Urszula Krzych, Walter Reed Army Institute of Research, USA
Title: Identification of novel pre-erythrocytic malaria antigens that enhance protection induced by circumsporozoite protein vaccines
![](images/speakers/136.jpg)
Wataru Akahata, VLP Therapeutics LLC, USA
Title: Development of a malaria vaccine using an alphavirus virus-like particle (i-aVLP) platform
![](images/speakers/49.jpg)
Wayne R. Hogrefe, Focus Clinical Trials, USA
Title: Tools to assess immunogenicity in the human ebola vaccine trials
![](images/speakers/89.jpg)
Yehia Abugabal, International Cancer Research Center, Egypt
Title: Cancer vaccines: a novel approach to cancer
![](images/speakers/43.jpg)
Young Chul Sung, POSTECH, Korea
Title: Therapeutic HPV DNA vaccine from bench to clinic
![](images/speakers/noimage.jpg)
Yu-jeong Won, The Catholic University of Korea, South Korea
Title: Full-length genomic sequence of sapovirus isolate in south korea
![](images/speakers/noimage.jpg)
Yun Wu, Protein Potential LLC, USA
Title: Development of a live attenuated oral vaccine against shigellosis and typhoid fever
![](images/speakers/90.jpg)
Zhikang Peng, University of Manitoba, Canada
Title: Peptide-based and virus-like particle therapeutic vaccines for allergic and autoimmune diseases
Keynote Speakers
![Jay A Berzofsky](images/speakers/109.jpg)
Jay A Berzofsky,
National Cancer Institute, USA
National Cancer Institute, USA
![Robert W Malone](images/speakers/110.jpg)
Robert W Malone,
RW Malone MD, LLC, USA
RW Malone MD, LLC, USA
![Manuel Elkin Patarroyo](images/speakers/140.jpg)
Samir N. Khleif,
GRU Cancer Center, USA
GRU Cancer Center, USA
![Myron M. Levine](images/speakers/112.jpg)
Myron M. Levine,
University of Maryland School of Medicine, USA
University of Maryland School of Medicine, USA
![Norman W. Baylor](images/speakers/113.jpg)
Norman W. Baylor,
Biologics Consulting Group, Inc., USA
Biologics Consulting Group, Inc., USA
![Manuel Elkin Patarroyo](images/speakers/118.jpg)
Manuel Elkin Patarroyo,
Fundacion Instituto de Inmunologia de Colombia, Colombia
Fundacion Instituto de Inmunologia de Colombia, Colombia
Bronze Sponsor
![Sanofi Pasteur](images/sponsors/sponsors1.jpg)
Bronze Sponsor
![Cellular Technology Limited (CTL)](images/indevr.jpg)
Supporting Sponsor
![AERAS](images/sponsors/sponsors21.jpg)
Supporting Sponsor
![LumaCyte](images/sponsors/sponsor3.jpg)
Exhibitor
![Cellular Technology Limited (CTL)](images/exhibitors/exhibitors.jpg)
![Become a Sponsor](images/become-a-sponsor.gif)